Bacteriemia por Staphylococcus aureus en niños

1. Larru B, Gong W, Vendetti N, Sullivan KV, Localio R, Zaoutis TE, et al. Bloodstream infections in hospitalized children. Pediatr Infect Dis J 2016;35:507-10.

2. Wisplinghoff H, Seifert H, Tallent SM, Bischoff T, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in pediatric patients in United States hospitals: epidemiology, clinical features and susceptibilities. Pediatr Infect Dis J 2003;22:686-91.

3. Richards MJ, Edwards JR, Culver DH, Gaynes RP. Nosocomial infections in pediatric intensive care units in the United States. National Nosocomial Infections Surveillance System. Pediatrics 1999;103:e39.

4. Le J, Dam Q, Tran T, Nguyen A, Adler-Shohet FC, Kim S, et al. Epidemiology and hospital readmission associated with complications of Staphylococcus aureus bacteremia in pediatrics over a 25-year period. Epidemiol Infect 2017;145:2631-9.

5. McNeil JC, Kok EY, Forbes AR, Lamberth L, Hulten KG, Vallejo JG, et al. Healthcare-associated Staphylococcus aureus bacteremia in children. Pediatr Infect Dis J 2016;35:263-8.

6. McMullan BJ, Bowen A, Blyth CC, VanHal S, Korman TM, Buttery J, et al. Epidemiology and mortality of Staphylococcus aureus bacteremia in Australian and New Zealand children. JAMA Pediatr 2016;170:979-86.

7. Asgeirsson H, Gudlaugsson O, Kristinsson KG, Vilbergsson GR, Heiddal S, Haraldsson A, et al. Low mortality of Staphylococcus aureus bacteremia in Icelandic children. Pediatr Infect Dis J 2015;34:140-4.

8. Cobos-Carrascosa E, Soler-Palac_in P, Nieves Larrosa M, Bartolom_e R Mart_in-Nalda A, Antoinette Frick M, et al. Staphylococcus aureus bacteremia in children. Pediatr Infect Dis J 2015;34:1329-34.

9. Hamdy RF, Hsu AJ, Stockmann C, Olson JA, Bryan M, Hersh AL, et al. Epidemiology of methicillin-resistant Staphylococcus aureus bacteremia in children. Pediatrics 2017;139:e20170183.

10. Gerber JS, Coffin SE, Smathers SA, Zaoutis TE. Trends in the incidence of methicillin-resistant Staphylococcus aureus infection in children’s hospitals in the United States. Clin Infect Dis 2009;49:65-71.

11. David MZ, Daum RS, Bayer AS, Chambers HF, Fowler VG, Miller LG, et al. Staphylococcus aureus bacteremia at 5 US academic medical centers, 2008-2011: significant geographic variation in community-onset infections. Clin Infect Dis 2014;59:798-807.

12. Kumarachandran G, Johnson JK, Shirley D-A, Graffunder E, Heil EL. Predictors of adverse outcomes in children with Staphylococcus aureus bacteremia. J Pediatr Pharmacol Ther 2017;22:218-26.

13. Burke RE, Halpern MS, Baron EJ, Gutierrez K. Pediatric and neonatal Staphylococcus aureus bacteremia: epidemiology, risk factors, and outcome. Infect Control Hosp Epidemiol 2009;30:636-44.

14. Cosgrove SE, Qi Y, Kaye KS, Harbarth S, Karchmer AW, Carmeli Y. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol 2005;26:166-74.

15. Hulten KG, Kaplan SL, Lamberth LB, Slimp K, Hammerman WA, Carrillo-Marquez M, et al. Hospital-acquired Staphylococcus aureus infections at Texas Children’s Hospital, 2001-2007. Infect Control Hosp Epidemiol 2015;31:183-90.